Complete title: A Phase 1/2 Study of Oral LOXO-305 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)
| Research Study Number | RG1007169 |
| Principal Investigator | Chaitra Ujjani |
| Phase | I/II |
Other eligibility criteria may apply.
| Research Study Number | RG1007169 |
Keywords: Leukemia, Chronic Lymphocytic (CLL); Waldenstrom Macroglobulinemia; Lymphoma, Mantle-Cell; Lymphoma, B-Cell; Lymphoma, Small Lymphocytic (SLL); Lymphoma, Marginal Zone
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.